Molecular imaging can accelerate anti-angiogenic drug development and testing-Reference-Cited by-同舟云学术

Molecular imaging can accelerate anti-angiogenic drug development and testing

Published:2007-08-28 Issue:10 Volume:4 Page:556-557
ISSN:1743-4254
Container-title:Nature Clinical Practice Oncology
language:en
Short-container-title:Nat Rev Clin Oncol

Author:

Iagaru Andrei,Chen Xiaoyuan,Gambhir Sanjiv Sam

Publisher

Springer Science and Business Media LLC

Subject

Oncology,General Medicine

Link

http://www.nature.com/articles/ncponc0929.pdf

Reference12 articles.

1. Gambhir SS (2002) Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2: 683–693

2. Cai W et al. (2006) How molecular imaging is speeding up antiangiogenic drug development. Mol Cancer Ther 5: 2624–2633

3. Brooks PC et al. (1994) Requirement of vascular integrin αvβ3 for angiogenesis. Science 264: 569–571

4. Haubner R et al. (2001) Noninvasive imaging of αvβ3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res 61: 1781–1785

5. Haubner R et al. (2005) Noninvasive visualization of the activated αvβ3 integrin in cancer patients by positron emission tomography and [18F]galacto-RGD. PLoS Med 2: e70

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular magnetic resonance imaging of Alpha-v-Beta-3 integrin expression in tumors with ultrasound microbubbles;Biomaterials;2021-08

2. Treating tumors with minimally invasive therapy: A review;Materials Science and Engineering: C;2020-03

3. PET/MRI in Brain Tumors;PET/MRI in Oncology;2018

4. Multimodality Imaging in Tumor Angiogenesis: Present Status and Perspectives;International Journal of Molecular Sciences;2017-08-28

5. Saving costs in cancer patient management through molecular imaging;European Journal of Nuclear Medicine and Molecular Imaging;2017-08-14